Clinical Decision Support System (CDSS) Market: Need for Preemptive Clinical Decision-Making Process Ushers Growth
Spike in voluminous data generation is constantly stoking global clinical decision support systems market. Pressing needs for optimum data mining for procuring valuable insights supporting impeccable medical output in the capacity of disease prognosis, subsequent therapeutic probabilities for value-based quality delivery of healthcare offerings are expected to sustain an optimistic growth track in global clinical decision making, finds Adroit Market Research in a new market intelligence survey documented in its humongous online data archive.
Request a pdf sample @ https://www.adroitmarketresearch.com/contacts/request-sample/1072
The global clinical decision support system market is anticipated to reach a value of USD 2,581.3 million by 2026, growing at a CAGR of 11.3% during the forecast period from 2020 to 2026. The growth of this market is driven by critical factors such as growing support from private institutions, keen adoption by government, growing penetration of tools such as mHealth and big data and better ROI statistics.
CDSS (clinical decision support system) is gaining mainstream status over the years as need for improved clinical decision-making backed by scalable healthcare data and ample patient information. The process is also to offer tremendous evidence-based response to clinical needs, focusing on the right set of professionals comprising the overall care delivery teams, involving the process of channelization such as electronic health record systems, smart devices and patient portals that are growing by the day.
Browse the full report with Table of Content and List of Figures at https://www.adroitmarketresearch.com/industry-reports/clinical-decision-support-systems-market
Rise in Respiratory Ailments such as Asthma to Induce Greater Reliance on CDSS
Critical diseases such as asthma which enforce precise disease management practices are better managed with clinical decision support system (CDSS). Factors such as step-up and step-down strategies comprising various elements such as risk prediction, seamless co-ordination between patients and care givers to appropriately monitor drug administration and track symptoms are well mediated with the help of agile CDSS platform. Rise in asthma instances apart from other disease occurrences such as COPD, cardiac ailments, neurological disorders and the like are likely to maintain rapid growth momentum in global clinical decision support system (CDSS) market in the forthcoming years.
Based on the components, the global clinical decision support system market has been classified into hardware, software and services. In base year 2019, services segment held a prominent share in the global market. The dominance of this segment is attributed to the incumbent nature of services in this market, which comprise activities such as installation, upgrade, maintenance etc. Furthermore, in terms of product types, the demand for integrated CDSS is the highest and the trend shall persist through the forecast period. Factors such as growing preference of hospitals and large scale healthcare institutions for integrated solutions including interconnected platforms and applications using a common database and interface is mainly attributed to this segment.
Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1072
Market participants in CDSS market are now eying for more agile solution process. for improved integration for impeccable medical decision-making.
Healthcare industry has constantly been challenged by discrepancies such as duplicity in test results, flawed patient safety system and the like that have propelled greater reliance on preemptive decision making for superlative therapeutic outcome and improved patient data safety, further resulting in a fruitful customer journey and customer experience. Functional integration with EHR for scalable workflows, streamlined processes in billing and record maintenance as well as robust alert systems make way for highly agile clinical decision support tools.
Based on regional demarcation, North America is the global leader in the clinical decision support systems market. The significant share of the region is contributed by growing demand for sophisticated healthcare, increased preference of healthcare organizations for patient service and satisfaction and the pre-existing robust healthcare infrastructure. Another factor attributed to the dominance of North America is the growing need to contain healthcare expenditure in the region, along with the growing incidence of medical errors in healthcare administration.
The global clinical decision support systems market is consolidated with a limited number of players offering holistic products in the market. Some of the major players include McKesson Corporation, IBM, Philips Healthcare, Cerner Corporation, Siemens Healthineers, Wolters Kluwer NU, Hearst Health, Elsevier B.V., Medical Information Technology, Inc., NextGen Healthcare Information Systems, Epic Systems Corporation and Allscripts Healthcare Solutions.
Enquire for in-depth information before buying this report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1072
Key Segments of the Global Clinical Decision Support System Market
Component Overview, 2016-2026 (USD Million)
- Hardware
- Software
- Services
Delivery Mode Overview, 2016-2026 (USD Million)
- On Premise
- Cloud
Product Overview, 2016-2026 (USD Million)
- Standalone CDSS
- Integrated CDSS
- Application Overview, 2016-2026 (USD Million)
- Drug-drug Interactions
- Drug Allergy Alerts
- Clinical Reminders
- Clinical Guidelines
- Drug Dosing Support
- Others
Regional Overview, 2016-2026 (USD Million)
- North America
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Major Points from Table of Contents:
- Introduction
- Research Methodology
- Market Outlook
- Clinical Decision Support System Market by Component, 2016-2026 (USD Million)
- Clinical Decision Support System Market by Product, 2016-2026 (USD Million)
- Clinical Decision Support System Market by Application, 2016-2026 (USD Million)
- Clinical Decision Support System Market by Delivery Mode, 2016-2026 (USD Million)
- Clinical Decision Support System Market by Region 2016-2026 (USD Million)
- Competitive Landscape
- Company Profiles
- Appendix
About Us:
Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us :
Ryan Johnson
Account Manager Global
3131 McKinney Ave Ste 600, Dallas,
TX 75204, U.S.A
Phone No.: USA: +1 972-362 -8199 / +91 9665341414
